Related Experiment Videos
Link between platelet activity and outcomes after an ischemic stroke.
Hon-Kan Yip1, Chia-Wei Liou, Hsueh-Wen Chang
1Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Niao Sung Hsiang, Kaohsiung Hsien, Taiwan, ROC.
Cerebrovascular Diseases (Basel, Switzerland)
|July 12, 2005
Summary
High platelet activity, indicated by CD62p expression, is linked to worse outcomes after ischemic stroke. Patients with high platelet activity faced significantly higher risks of death, recurrent stroke, and severe neurological impairment.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Hematology
Background:
- Platelets are crucial in atherosclerosis and thromboembolic events.
- Understanding platelet activity post-ischemic stroke is vital for predicting outcomes.
Purpose of the Study:
- To investigate the association between circulating platelet activity and clinical outcomes in patients following an ischemic stroke.
Main Methods:
- Flow cytometry was used to measure platelet activity (CD62p expression) at multiple time points post-stroke.
- 92 ischemic stroke patients were categorized into high and low platelet activity groups based on early phase CD62p expression levels.
Main Results:
- High platelet activity was significantly associated with a higher incidence of composite endpoints (death, recurrent stroke, severe neurological impairment) within 30 days and at intermediate-term follow-up.
- Independent predictors of adverse outcomes included high platelet activity, advanced age, and coronary artery disease.
Conclusions:
- Elevated platelet activity in the early phase of ischemic stroke is a strong predictor of adverse clinical outcomes.
- These findings highlight the prognostic value of monitoring platelet activation in stroke patients.